Li Xuelin, Tang Jinfa, Meng Fei, Li Chunxiao, Xie Yanming
The First Affiliated Hospital of Henan College of Pharmacy, Zhengzhou 450000, China.
Zhongguo Zhong Yao Za Zhi. 2011 Oct;36(20):2783-5.
To study Danhong injection adverse reactions (ADR) incidence, nature and clinical performance, provide the basis for the clinical safety of drugs.
Multi-center, a large sample of hospitals focused on monitoring method.
Danhong injection ADR for the rapid onset and ease the quick recovery, the rate was 0. 682% , the newly discovered ADR constipation, sweating, tinnitus, irritability, joint disease, erythema, venous pain, phlebitis, local numbness, pain, weakness, gastrointestinal ulcer bleeding, vasospasm, cyanosis.
Danhong injection adverse reactions are type A adverse reactions occasionally, centralized monitoring of hospital medicine injection method is to carry out post-marketing safety re-evaluation of appropriate methods.
研究丹红注射液不良反应（ADR）的发生率、性质及临床表现，为临床用药安全性提供依据。
采用多中心、大样本医院集中监测方法。
丹红注射液不良反应起病迅速且缓解快，发生率为0.682%，新发现的ADR有便秘、出汗、耳鸣、烦躁、关节不适、红斑、静脉疼痛、静脉炎、局部麻木、疼痛、乏力、消化道溃疡出血、血管痉挛、发绀。
丹红注射液不良反应偶见A型不良反应，医院集中监测药品注射方法是开展上市后安全性再评价的适宜方法。
